MARKSANS vs GKSL: Stock Comparison
Head-to-head financial and trading comparison between Marksans Pharma Limited (MARKSANS) and Gujarat Kidney And Super Speciality Limited (GKSL) in the Cross-Sector Peers sector.
MARKSANS
NSE: MARKSANSGKSL
NSE: GKSLKey Metrics Comparison Table
| Metric | MARKSANS | GKSL | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹309.10 | ₹184.09 | — |
| 1-Year Price Return | +74.73% | +63.49% | MARKSANS (11.24% higher) |
| 52-Week High | ₹347.60 | ₹194.27 | — |
| 52-Week Low | ₹176.77 | ₹110.40 | — |
| 30-Day Annualized Volatility | 42.37% | 44.2% | MARKSANS (Steadier) |
| 30-Day Average Daily Volume | 2,394,723 | 2,108,623 | MARKSANS (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MARKSANS and GKSL, which stock gave better returns over the last year?
MARKSANS has outperformed GKSL over the past 12 months with a gain of 74.73% compared to 63.49%.
Which stock is less volatile: MARKSANS or GKSL?
MARKSANS demonstrated lower price volatility (42.37% annualized) compared to GKSL (44.2%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MARKSANS vs GKSL?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MARKSANS and GKSL direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.